Docusign, INC Form 4 insider transactions

DocuSign's President General Manager of Growth, Robert Chatwani, has scheduled the sale of 983 shares of common stock for $68.62 per share under a Rule 10b5-1 plan.

DocuSign Director Anna Marrs reported the vesting of 725 restricted stock units and the subsequent sale of 363 common shares under a Rule 10b5-1 plan.

DocuSign Director Michael George Rosenbaum converted 522 Restricted Stock Units into common stock, increasing his direct ownership.

DocuSign Director Enrique T. Salem acquired 729 shares of common stock through the conversion of restricted stock units.

DocuSign Director Mary Agnes Wilderotter acquired 729 shares of common stock through the vesting of Restricted Stock Units.

DocuSign Director Teresa Briggs executed a planned sale of 365 common shares and acquired 729 shares through RSU vesting, increasing her total direct ownership.

DocuSign Director Cain A. Hayes acquired 729 shares of common stock through the vesting of Restricted Stock Units on November 29, 2025.

DocuSign Director Blake Irving converted 729 Restricted Stock Units into common stock, increasing his direct common stock holdings.

DocuSign Director Peter Solvik acquired 729 shares of common stock through the vesting of Restricted Stock Units, increasing his direct beneficial ownership.

DocuSign Director James A. Beer reported the sale of 450 common shares and the conversion of 729 Restricted Stock Units into common stock.

DocuSign Director Anna Marrs reported the acquisition of shares from RSU vesting and a subsequent sale of common stock under a pre-arranged 10b5-1 plan.

DocuSign's Chief Revenue Officer, Paula Hansen, sold 6,000 shares of common stock through a pre-arranged 10b5-1 plan, following an acquisition of 245 shares via an employee stock purchase plan.

DocuSign's President and CEO, Allan C. Thygesen, sold 40,000 shares of common stock on October 1, 2025, through a pre-arranged Rule 10b5-1 trading plan.

DocuSign's Chief Financial Officer, Blake Jeffrey Grayson, sold 6,500 shares of common stock for approximately $462,811 under a pre-arranged 10b5-1 plan.

DocuSign's Chief Legal Officer, James P. Shaughnessy, sold 7,500 shares of common stock for approximately $534,111 under a pre-arranged 10b5-1 trading plan.

DocuSign's Chief Financial Officer, Blake Jeffrey Grayson, sold 9,509 shares of common stock on September 17, 2025, through a pre-arranged Rule 10b5-1 trading plan.

Robert Chatwani, DocuSign's President General Manager of Growth, sold 13,817 shares of common stock on September 17, 2025, through a pre-arranged Rule 10b5-1 trading plan.

DocuSign Director James A. Beer sold 450 shares of common stock for $81.28 per share under a pre-arranged 10b5-1 trading plan.

DocuSign Director Peter Solvik sold 15,000 shares of common stock for over $1.2 million, executed under a Rule 10b5-1 plan.

DocuSign's Chief Legal Officer, James P. Shaughnessy, reported the vesting of various restricted and performance stock units and subsequent tax-related share withholding on September 15, 2025.

DocuSign CEO Allan Thygesen reported the vesting of 65,558 equity awards and the subsequent sale of 33,295 shares for tax obligations, increasing his direct beneficial ownership to 176,246 shares.

DocuSign's President of Growth, Robert Chatwani, filed a Form 4 detailing future stock sales and equity award vestings scheduled for September 15, 2025.

DocuSign's Chief Financial Officer, Blake Jeffrey Grayson, reported the vesting of restricted and performance stock units, alongside shares withheld for tax obligations.

DocuSign's Chief Revenue Officer, Paula Hansen, reported the vesting of equity awards and subsequent tax-related share dispositions.

DocuSign Director Anna Marrs reported a planned sale of 728 shares of common stock for $80.3 per share, scheduled for September 15, 2025, under a Rule 10b5-1 plan.

DocuSign's President General Manager of Growth, Robert Chatwani, sold 983 shares of common stock for $79.39 per share on September 11, 2025.

DocuSign Director Teresa Briggs sold 364 shares of common stock for $79.39 per share on September 11, 2025, as part of a Rule 10b5-1 trading plan.

DocuSign Director Michael George Rosenbaum was granted 6,265 Restricted Stock Units, vesting quarterly over three years starting September 3, 2025.

DocuSign Director Anna Marrs reported the conversion of 725 restricted stock units into common stock, part of a pre-arranged vesting schedule.

DocuSign Director Enrique T. Salem reported the conversion of 729 Restricted Stock Units into common stock, increasing his direct holdings.